Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLACOTCMKTS:SIGYOTCMKTS:UMGPOTCMKTS:VYCO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLACBellevue Life Sciences Acquisition$1.35-2.9%$1.34$3.01▼$13.40$5.46M-0.0821,570 shs120,923 shsSIGYSigyn Therapeutics$2.75$3.07$2.49▼$5.75$4.43M-1.15100 shsN/AUMGPDalton Industries$0.03-19.9%$0.03$0.02▼$0.29$994K0.042,126 shs3,000 shsVYCOVycor Medical$0.13$0.13$0.04▼$0.50$4.42M-0.421,531 shsN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLACBellevue Life Sciences Acquisition-7.95%+11.20%+6.11%-5.44%-87.13%SIGYSigyn Therapeutics0.00%0.00%+10.44%-33.73%-47.62%UMGPDalton Industries0.00%-19.88%+3.45%-10.00%-80.58%VYCOVycor Medical0.00%0.00%+12.07%+103.94%+46.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLACBellevue Life Sciences Acquisition 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/AUMGPDalton Industries 0.00N/AN/AN/AVYCOVycor Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/A($2.78) per shareN/AUMGPDalton Industries$30K33.12N/AN/AN/A∞VYCOVycor Medical$1.59M2.78N/AN/A($0.11) per share-1.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ASIGYSigyn Therapeutics-$3.34M-$4.57N/A∞N/AN/AN/A-2,014.27%N/AUMGPDalton Industries-$350K-$0.01N/A∞N/AN/AN/AN/AN/AVYCOVycor Medical-$110KN/A0.00∞N/A-6.86%N/A-11.44%8/11/2025 (Estimated)Latest UMGP, SIGY, BLAC, and VYCO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025SIGYSigyn TherapeuticsN/A-$0.42N/A-$0.42N/AN/A5/15/2025Q1 2025VYCOVycor MedicalN/A-$0.01N/A-$0.01N/A$0.44 million4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLACBellevue Life Sciences AcquisitionN/AN/AN/ASIGYSigyn TherapeuticsN/A0.010.01UMGPDalton IndustriesN/AN/AN/AVYCOVycor MedicalN/A0.130.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLACBellevue Life Sciences Acquisition55.30%SIGYSigyn Therapeutics10.01%UMGPDalton IndustriesN/AVYCOVycor MedicalN/AInsider OwnershipCompanyInsider OwnershipBLACBellevue Life Sciences Acquisition33.67%SIGYSigyn Therapeutics78.46%UMGPDalton IndustriesN/AVYCOVycor Medical7.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableUMGPDalton Industries2436.80 millionN/ANot OptionableVYCOVycor Medical633.42 million31.07 millionNot OptionableUMGP, SIGY, BLAC, and VYCO HeadlinesRecent News About These CompaniesVYCO Vycor Medical, Inc.May 31, 2025 | seekingalpha.comVycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 14, 2025 | finance.yahoo.comEQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 13, 2025 | markets.businessinsider.comMedical ethics articles from across Nature PortfolioOctober 22, 2024 | nature.comNBlueChew Review 2024January 17, 2024 | medicalnewstoday.comMWhat to know about bleeding hemorrhoidsDecember 19, 2023 | medicalnewstoday.comMCommon symptoms of depression: What to knowOctober 11, 2023 | medicalnewstoday.comMVycor Medical, Inc. (VYCO)January 7, 2023 | finance.yahoo.comMedical Review BoardNovember 1, 2022 | health.usnews.comMedical Scholars ProgramSeptember 12, 2022 | slu.eduSVycor Medical IncSeptember 8, 2022 | reuters.comMinnetronix commercializes its own product: a minimally invasive deep brain access portAugust 20, 2022 | medcitynews.comMViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMay 11, 2022 | nice.org.ukNVycor Medical Year to Date Total Returns (Daily)January 2, 2022 | ycharts.comYVycor Medical Inc (VYCO)December 17, 2021 | nasdaq.comThe journal of physical chemistry. BOctober 18, 2021 | medscape.comMMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeNew Catalysts to Drive NVIDIA’s Stock Price Even HigherBy Thomas Hughes | June 16, 2025View New Catalysts to Drive NVIDIA’s Stock Price Even HigherUMGP, SIGY, BLAC, and VYCO Company DescriptionsBellevue Life Sciences Acquisition NASDAQ:BLAC$1.35 -0.04 (-2.88%) As of 07/3/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Sigyn Therapeutics OTCMKTS:SIGY$2.75 0.00 (0.00%) As of 07/1/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.Dalton Industries OTCMKTS:UMGP$0.03 -0.01 (-19.88%) As of 07/1/2025 09:32 AM EasternUniversal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida.Vycor Medical OTCMKTS:VYCO$0.13 0.00 (0.00%) As of 07/3/2025Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
